Objectives: To characterize hospital phenotypes by their combined utilization pattern of percutaneous coronary interventions (PCI), coronary artery bypass grafting (CABG) procedures, and intensive care unit (ICU) admissions for patients hospitalized for acute myocardial infarction (AMI).
U sing advanced analytics of pattern recognition, recent big data research revealed important similarities and differences among hospitals in provision of care. [1] [2] [3] In contrast with conventional studies that analyze how hospitals deviate from an average tendency in care, the approach of pattern recognition explores whether there are distinct "phenotypes" among hospitals, representing fundamentally different patterns of care. 4 By characterizing hospital practice phenotypes and comparing their financial and patient outcomes, we can inform strategies to improve the value of hospital care.
Acute myocardial infarction (AMI) is an ideal condition to study hospital practice patterns. AMI is among the most common and expensive conditions requiring hospitalization in the United States, with 612,000 admissions and an average hospital cost of $18,900 in 2011. 5, 6 Underneath the average hospitalization cost, there was substantial variation among hospitals-after adjustment for patient case-mix, costs of a 30-day episode of care following an AMI admission ranged from $13,909 to $28,979 across 2382 hospitals nationwide in 2008-2009. 7 Likewise, riskstandardized 30-day mortality rate for Medicare fee-forservice beneficiaries with AMI varied from 10.9% to 24.9% among 2908 hospitals in the United States in 2005-2008. 8 These data suggest potentially large difference in how hospitals manage patients hospitalized for AMI.
Moreover, prior research suggests that determinants of cost for AMI hospitalizations are multifactorial, highlighting the need to study practice patterns across multiple aspects of care. Different procedure use, such as percutaneous coronary intervention (PCI) versus coronary artery bypass grafting (CABG), entails different levels of resource intensity, which has been shown to contribute importantly to cross-country differences in cost of AMI hospitalizations. 9 Other studies also found that the proportion of patients receiving PCI influences hospitalization costs more than other treatment strategies, 10 whereas changes in the costs of intensive care unit (ICU) contributed substantially to the growth of hospitalization costs in the United States. 11 Therefore, practices related to PCI, CABG, and ICU use may be important indicators of care patterns and may present opportunities to optimize utilization. Surprisingly, little is known about how hospitals differ in their practice of care for AMI. The purpose of this study was to assess whether distinct phenotypes of PCI, CABG, and ICU use are present among hospitals for patients hospitalized for AMI. To capture evolving practice in AMI care, such as increasing use of PCI over time, 12 our classification of hospital phenotypes also accounted for temporal changes in utilization measures. We compared costs, mortality, and readmission outcomes between hospital phenotypes to identify practice patterns providing the best value of care, and examined which hospital characteristics were associated with specific phenotypes. Findings from this study can inform subsequent hypothesis development, testing, and prediction to elucidate important contributors to hospital variation in practices.
METHODS

Data Source and Patient Population
We used the Premier Analytical Database maintained by Premier Inc. (Charlotte, NC). This database includes administrative and operational data from a large network of hospitals in the United States and ancillary providers nationwide. It contains a date-stamped log of all billed items and resource utilization during hospitalizations (eg, blood, medications, and laboratory, diagnostic, and therapeutic services), diagnosis and procedure codes, and patient and hospital characteristics. Patient-level data were deidentified in accordance with the Health Insurance Portability and Accountability Act.
The study cohort included all hospitalizations with a principal diagnosis of new AMI, that is, International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) codes 410.xx [except for 410.x2 (AMI, subsequent episode of care)], discharged from hospitals capable of performing open-heart surgery during January 2010-December 2013. Whether a hospital had the capacity to perform open-heart surgery was determined based on its response to this question in the American Hospital Association annual survey.
We excluded hospitalizations attended by pediatricians, hospitalizations that were transferred from or to another acute care facility (because we could not link hospitalizations across hospitals), hospitalizations that involved a heart transplant or left ventricular assist device (LVAD) implantation (because such patients were not representative of the general AMI population), and hospitalizations with a length of stay of 1 day or less in which the patient was discharged alive, to eliminate unlikely AMIs. In addition, we excluded hospitalizations for patients younger than 65 years to be consistent with the age criterion for the Centers for Medicare & Medicaid Services (CMS) publicly reported mortality, readmission, and payment measures, which we used to measure longer-term outcomes.
This study is under a collaborative contract with Premier Inc. regarding protection of privacy of hospitals and other providers. The Yale University Human Investigation Committee exempted this study protocol as defined by the Office of Human Research Protections.
PCI Procedure, CABG Procedure, and ICU Admission
For each hospitalization, we measured whether the patient received a PCI or CABG procedure, and whether the patient was admitted to an ICU. Receipt of PCI and CABG procedures was determined based on ICD-9-CM procedure codes (PCI: 00.66, 36.01, 36.02, and 36.05-36.07; CABG: 36.1, 36.10-36.17, and 36.19) and hospital charge codes for PCI and CABG services, respectively. ICU admission was identified based on hospital charge codes for ICU services.
Cost, Mortality, and Readmission Outcomes
We measured in-hospital cost and in-hospital mortality for each AMI hospitalization. Methods for estimating inhospital cost are detailed elsewhere. 3, 13 Briefly, we used accounting cost data available in the Premier database and removed geographic variation in input prices by applying average unit cost across all hospitals for each service item by year. All cost estimates were adjusted to 2013 US dollars. 14 We Winsorized cost data within each year at the 0.5th and 99.5th percentiles to reduce the influence of outliers. [15] [16] [17] Because patients were deidentified, we were unable to track their outcomes postdischarge and hence measured in-hospital mortality for each hospitalization.
To assess longer-term financial and health outcomes at the hospital level, we linked hospitals in our sample to CMS public reporting data on 2010-2013 hospital-specific 30-day risk-standardized mortality rate (RSMR), 30-day riskstandardized readmission rate (RSRR), and 30-day riskstandardized payment (RSP). [18] [19] [20] Although RSP did not directly measure costs, it can serve as an approximation for resource utilization over the 30-day episode of care. 20 
Hospital Characteristics
Hospital structural, financial, and capacity characteristics were available from the Premier Analytical Database with some of the measures obtained from the American Hospital Association annual survey. We constructed additional measures based on each hospital's AMI hospitalizations in pooled 2010-2013 data (regardless of aforementioned exclusion criteria), including average annual volume of AMI hospitalizations, proportions of AMI hospitalizations covered by Medicare or Medicaid, proportion of AMI patients who were African American, proportion of AMI hospitalizations with a cardiologist as the attending physician, proportion of AMI hospitalizations that were transferred from or to another acute care facility, and whether the hospital performed any LVAD implantation or heart transplant.
Statistical Analysis
We assigned each hospitalization to a year based on its discharge date. For each hospital year, we estimated riskstandardized measures of PCI procedure rate, CABG procedure rate, and ICU admission rate, as well as riskstandardized in-hospital cost and in-hospital mortality rate, by adjusting for patient case-mix using hierarchical generalized linear models. Candidate risk adjustors included patient age, an indicator for ST-segment-elevation myocardial infarction (vs. non-ST-segment-elevation myocardial infarction), 21 comorbidities, 22, 23 prior PCI and CABG history, and proportion of the corresponding hospital year's AMI patients who were transferred from another acute care facility, were transferred to another acute care facility, or received a heart transplant or LVAD implantation. The latter 3 variables acted as markers for expected patient severity in a given hospital year. We used stepwise selection to determine risk adjustors in the final model. Hereafter all measures refer to their risk-standardized estimates unless otherwise specified.
To identify distinct hospital phenotypes, we analyzed hospital-level, risk-standardized estimates of PCI procedure rate, CABG procedure rate, and ICU admission rate using a group-based growth-mixture modeling approach. 4, 24 Because hospitals had multiple years of data, each utilization measure was characterized by a trajectory. The model simultaneously analyzed trajectories of all 3 measures and assumed that there were distinct hospital groups (ie, phenotypes) based on the joint pattern of these trajectories. Shapes of the trajectories and size of each group were estimated through maximum likelihood estimation. Trajectories of hospital PCI and CABG rates were best modeled as a linear function of time, where time reflected the number of years since 2010. The trajectory of ICU admission rate was best modeled as a cubic function of time. We determined the optimal number of phenotypes based on several criteria by comparing alternative models with different numbers of groups: the Bayesian Information Criteria (BIC) index, average posterior probability of phenotype membership, 95% confidence intervals of adjacent trajectories, size of the smallest phenotype, and whether additional phenotypes identified in successive models represented substantially distinct pheno-types or mere subdivisions of major phenotypes already identified. 4 Posterior probability of phenotype membership was calculated based on Bayes' theorem, reflecting each hospital's probability of belonging to a particular phenotype given its observed utilization measures (with higher posterior probability indicating better model performance). 4 We included all eligible hospitalizations in the risk-adjustment models. However, to provide reliable estimates of hospitals' longitudinal trajectories, we limited the phenotype analysis to hospitals with 25 AMI hospitalizations in at least 1 year.
We then examined whether the identified hospital phenotypes differed significantly in in-hospital cost, in-hospital mortality rate, and 30-day RSMR, RSRR, and RSP. Because in-hospital cost and in-hospital mortality rates were assessed annually, we modeled each measure as a function of hospital phenotype and year using a generalized estimation equation model to control for hospital correlation over time. We used statistical significance level of coefficient estimates on the hospital phenotype indicators as the P-values for the association between phenotype and treatment outcomes. Because 30-day RSMR, RSRR, and RSP were cross-sectional measures for the 2010-2013 public report period, we used the Wilcoxon rank-sum test to compare their differences across hospital phenotypes.
We also assessed the association of hospital phenotype with various hospital characteristics through bivariate analyses and a multinomial logistic regression model (dependent variable = hospital phenotype). Hospital characteristics that differed significantly across phenotypes in bivariate analyses were included as candidate explanatory variables in the regression model and stepwise selection was used to determine variables for the final model.
P-values <0.05 were considered statistically significant. When conducting pairwise comparisons between the phenotypes, we used the Bonferroni method to calculate adjusted P-values to account for multiple comparisons. More details regarding our analytical methods are in Supplemental Digital Contents 1-3 (http://links.lww.com/MLR/B204, http://links.lww.com/MLR/B205, http://links.lww.com/MLR/ B206). All analyses were conducted using SAS 9.3 (SAS Institute Inc., Cary, NC). Graphs were generated using R. 25 
RESULTS
Hospital Variation in PCI, CABG, and ICU Use
We identified 129,262 hospitalizations for AMI from 248 hospitals that were capable of performing open-heart surgery. Of these, 246 (99.2%) hospitals had Z25 hospitalizations for at least 1 year and were included in our analysis of hospital phenotypes. They contributed 129,138 (99.9%) AMI hospitalizations, with 237 hospitals (96.3%) having at least 2 years of data and 167 (67.8%) having all 4 years of data. These hospitals were mostly nonteaching, medium to large size, and served urban populations (Table 1) .
Among the 246 hospitals, after adjustment for patient case-mix, PCI, CABG, and ICU use all varied widely across hospitals in any given year (see Figure, Supplemental Digital Content 4, http://links.lww.com/MLR/B207, which illustrates variation in these 3 measures by year). For example, in 2013, PCI procedure rates, CABG procedure rates, and ICU admission rates ranged from 22.5% to 64.0%, 5.6% to 22.1%, and 0.7% to 93.5%, respectively, across hospitals. The hospital-level rates of PCI and CABG remained relatively stable during 2010-2013, whereas ICU admission rates slightly declined in 2011 but returned to their initial levels afterward.
Hospital Phenotypes
We selected a 3-phenotype model because the BIC score plateaued after 3 groups and a model with 3 phenotypes achieved better average posterior probability of phenotype membership ( > 0.89 for all 3 phenotypes) than models with more phenotypes. The 3 phenotypes exhibited different patterns of care for patients hospitalized for AMI ( Fig. 1) : 
Phenotype 1: High PCI-Low CABG-High ICU Admission (39.2% of Hospitals)
Hospitals in this phenotype had high rates of PCI procedures and ICU admissions (45.3% and 65.4%, respectively, in 2010). However, they had low CABG rates (9.4% in 2010).
Phenotype 2: High PCI-Low CABG-Low ICU Admission (30.5% of Hospitals)
Compared with hospitals in phenotype 1, those in phenotype 2 had similar rates of PCI and CABG procedures (45.5% and 9.1%, respectively, in 2010), but much lower ICU admission rates (38.8% in 2010).
Phenotype 3: Low PCI-High CABG-Moderate ICU Admission (30.4% of Hospitals)
Hospitals in this phenotype had moderate rates of ICU admission (48.6% in 2010). Their rates of PCI procedures were much lower than other phenotypes (36.3% in 2010) yet their rates of CABG procedures were higher than the other phenotypes (10.9%).
Although the absolute difference in CABG procedure rate between phenotypes is modest, it reflects a meaningful, relative difference in practice given the generally low rate of CABG. The CABG rate of 10.9% in phenotype 3 is nearly 20% higher than the rate in phenotype 2 (ie, 9.1%). The difference in PCI, CABG, and ICU use among the phenotypes remained stable over time.
Hospital Characteristics Associated With Phenotypes
Hospitals in the 3 phenotypes are largely similar in the characteristics assessed (Table 2 ). Only geographic region was significantly associated with a hospital's phenotype membership (P = 0.03). This was confirmed in multivariable regression analysis, where we assessed adjusted association of hospital characteristics with the phenotypes. Only geographic region remained statistically significant in this model (see Table, Supplemental Digital Content 5, http://links. lww.com/MLR/B208, which reports results from multinomial logistic regression regarding adjusted association of hospital characteristics with the phenotypes). Compared with hospitals in the South, those in the Midwest were more likely to have high PCI-low CABG-high ICU admission (odds ratio = 2.83, P = 0.005) or high PCI-low CABG-low ICU After adjusting for patient case-mix, high PCI-low CABG-high ICU hospitals had higher in-hospital cost than the other 2 phenotypes (P < 0.001 for both), averaging $21,139 per patient ( Fig. 2 ; also see Table, Supplemental Digital Content 6, http://links.lww.com/MLR/B209: summary statistics of costs and patient outcomes). Likewise, these hospitals also had higher 30-day RSP than hospitals in low PCI-high CABG-moderate ICU admission phenotype ($22,266 vs. $21,566, P = 0.005).
In terms of patient outcomes, there was no statistically significant difference in in-hospital RSMR among the 3 hospital phenotypes nor did the 3 phenotypes differ in 30-day RSMR or 30-day RSRR.
DISCUSSION
In a large sample of US hospitals, we identified 3 distinct phenotypes of hospital practice for AMI hospitalizations after adjusting for patient case-mix. These phenotypes were associated with different cost profiles yet similar patient outcomes. Hospitals in these phenotypes differed by geographic region.
Our study extends prior research by classifying distinct hospital groups according to the combined pattern of 3 practice indicators-PCI procedure rate, CABG procedure rate, and ICU admission rate. On the basis of observed data pattern, the group-based growth-mixture model used in our analysis empirically determined the optimal number of distinct hospital groups and the shape of each group (ie, level of care and rate of change in care over time for each practice indicator). Moreover, by modeling multiple practice indicators, our approach informs how hospitals deploy multiple resources in different compositions (eg, procedures, ICU admission). We found that 1 hospital phenotype used more CABG procedures but fewer PCI procedures and had moderate ICU admission rates. In contrast, the remaining 2 phenotypes both had high PCI procedure rates and low CABG rates, but 1 had high ICU admission rates whereas the other had low ICU admission rates. Although variation in CABG rates was modest across the phenotypes, PCI procedure rates and ICU admission rates differed substantially, ranging from 36.3% to 45.5% and from 38.8% to 65.4%, respectively. These phenotypes were identified after adjustment for patient case-mix, indicating that they did not emerge because of patient differences and there may be opportunities to improve efficiency.
Our assessment of a wide range of hospital characteristics only identified geographic region as a factor associated with the phenotypes. This is consistent with earlier research showing regional variation in other AMI-related care such as utilization of coronary angiography. 26, 27 Our findings extend this literature by depicting the relationship of geographic region with multidimensional practice patterns. More in-depth investigation of hospital attributes (eg, qualitative assessment of institutional policies and protocols regarding patient selection for revascularization procedures and ICU admissions at hospitals in different phenotypes) will further inform the underlying reasons for the variation. 28 Moreover, some factors that influence practice patterns may be at the physician level, calling for more research on physician-hospital dynamics (eg, engagement of physicians by hospitals in quality, safety, and cost containment initiatives). 29, 30 Another contribution of this study is our comparison of "value," that is, the combination of cost and patient outcomes (mortality and readmission), associated with the different hospital phenotypes. Care patterns that produce good outcomes at lower costs signal higher-value care, and hospitals with such patterns warrant closer investigation to fully understand their exemplary experience. Costs should not be evaluated in isolation from patient outcomes. In our analysis, average in-hospital cost and 30-day episode of care payment for an AMI patient hospitalized in high PCI-low CABGhigh ICU admission hospitals were $1456 and $700, respectively, higher than low PCI-high CABG-moderate ICU hospitals. Yet these hospitals achieved similar mortality and readmission rates, suggesting no obvious gains in health outcomes. With the large number of AMI hospitalizations each year, the overall financial impact of the different care patterns can be substantial. Moreover, given that the high PCI-low CABG-high ICU admission hospitals had similar mortality and readmission outcomes as high PCI-low CABG-low ICU admission hospitals, there may be opportunities to reduce ICU utilization without comprising quality of care. While we recognize that our analysis only assessed associations and cannot infer causal relationships, this approach offers a novel and useful tool for classifying hospital performance. Further investigation is needed to extend our understanding of financial and health consequences of the different hospital phenotypes and the possibility of safely shifting lower-value hospitals to a higher-value profile. For example, additional research incorporating data on postdischarge care is needed, as such care might differ across the phenotypes and contribute to 30-day outcomes as well.
Several limitations of our study should be acknowledged. First, the Premier database included a voluntary network of hospitals. Although it consisted of a large sample of hospitals with diverse characteristics, our findings may not be generalizable to other hospitals in the United States. Second, our measurement of risk factors relied on information available in administrative data. We also had limited information on physicians' characteristics (eg, skills) and patients' coronary anatomy (eg, multivessel or left main stem disease), which may influence clinical decisions regarding the choice between PCI and CABG for revascularization. 31 However, earlier work on AMI demonstrated that administrative data can provide estimates of hospital performance similar to models that use richer clinical data. 32 Third, due to the deidentified nature of the data, we measured PCI and CABG history based on records within the same hospital, which might underestimate prior revascularization in risk adjustment. However, we found no systematic difference in documentation of prior PCI/CABG across hospitals. The influence on our estimated hospital variation in revascularization rate is likely small. Finally, even 30-day outcomes may not fully capture the benefit of revascularization procedures. Future studies with longer-term follow-up will provide additional insights.
The current US health care system could benefit from innovative and rigorous research identifying treatment patterns that yield high-value care (ie, good outcomes at lower cost). By examining the combined pattern of PCI procedure use, CABG procedure use, and ICU admission, we identified 3 distinct hospital phenotypes for the management of AMI hospitalizations that are not, to the extent possible, due to differences in patient clinical characteristics. These practice patterns were associated with similar patient outcomes but had very different cost implications, suggesting that some hospital phenotypes may be more successful in producing high-value care. The financial and health impact of moving hospitals from one phenotype to another warrants further investigation.
